HPRA Drug Safety Newsletter Edition 86
Download:
hpra-drug-safety-newsletter-edition-86.pdf
297 KB
The latest edition of the HPRA Drug Safety Newsletter (DSN) includes important updates to support the safe and appropriate use of the following medicines:
Esmya 5mg Tablets (Ulipristal acetate)
Important new warnings of serious liver injury and recommendations for liver monitoring
Xofigo (radium-223 dichloride)
Contraindicated in combination with Zytiga (abiraterone acetate) and prednisone/prednisolone
Mycophenolate
Updated contraceptive advice for male patients
Oral Retinoids
Outcome of EU review and updated warnings
Zinbryta (daclizumab beta)
EMA recommends immediate suspension and recall
« Back